Segment, Geographical and Other Revenue Information - Goodwill (Details) - USD ($) $ in Thousands |
Mar. 31, 2020 |
Dec. 31, 2019 |
|---|---|---|
| Segment Reporting Information [Line Items] | ||
| Goodwill | $ 3,241 | $ 3,241 |
| Performance Enzymes [Member] | ||
| Segment Reporting Information [Line Items] | ||
| Goodwill | 2,400 | |
| Novel Biotherapeutics [Member] | ||
| Segment Reporting Information [Line Items] | ||
| Goodwill | 800 | |
| Operating Segments [Member] | ||
| Segment Reporting Information [Line Items] | ||
| Goodwill | 3,241 | 3,241 |
| Operating Segments [Member] | Performance Enzymes [Member] | ||
| Segment Reporting Information [Line Items] | ||
| Goodwill | 2,463 | 2,463 |
| Operating Segments [Member] | Novel Biotherapeutics [Member] | ||
| Segment Reporting Information [Line Items] | ||
| Goodwill | $ 778 | $ 778 |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|